Tuesday, September 7 | 11:00 CET (EET = +1hr / BST = -1hr / EST = -6hr)
Open to 25 CEO, Founder, Co-Founder, President, Chairman or c-suite executives (CFO, CBO, CCO, CSO, CMO) of Nordic heathtech and digital health startups.
Free to attend, pre-registration only, Chatham House Rule forum hosted on Zoom where all participants are active discussants.
11:00 LSX Welcome
11:05 Overview Of The Nordic Healthtech Market’s Development
Marianne Larsson, Director, Healthtech Nordic
Christer Månsson, Business Development Manager, Healthtech Nordic
11:20 Q&A and Discussion
11:25 Valuations And The Important Role Of A Heathy Intellectual Property Portfolio Plays For Healthtech Companies
Intellectual property is typically one of the first asset classes a company will own, and in life sciences it can be one of the most valuable. However, in the early stages of building a company the value of intellectual property is often underestimated, which can impact on future valuations.
Chris Cadman, Senior Associate, Potter Clarkson
11:40 Q&A and Discussion
11:45 Securing Successful Partnerships With Biotech And Pharma As A Healthtech Business
John Drakenberg Renander, CEO, Alex Therapeutics
12:05 Q&A and Discussion
12:10 General Discussion
Topics to include:
12:45 End Of Forum
This session takes place as part of the LSX Nordic Congress.
If you qualify can attend for free by registering for the 'Content Only' pass via the main registration page.
If you are unsure if this session is for you please contact email@example.com